1247 related articles for article (PubMed ID: 28637758)
21. A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.
Feng FT; Cui Q; Liu WS; Guo YM; Feng QS; Chen LZ; Xu M; Luo B; Li DJ; Hu LF; Middeldorp JM; Ramayanti O; Tao Q; Cao SM; Jia WH; Bei JX; Zeng YX
Chin J Cancer; 2015 Dec; 34(12):563-72. PubMed ID: 26675171
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC).
Liu Y; Yang W; Pan Y; Ji J; Lu Z; Ke Y
Oncotarget; 2016 Jan; 7(4):4903-14. PubMed ID: 26716899
[TBL] [Abstract][Full Text] [Related]
23. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
24. [Study of sequence variations of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma].
Lin SX; Zong YS; Zhang M; Han AJ; Zhong BL; Liang YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):791-5. PubMed ID: 16545188
[TBL] [Abstract][Full Text] [Related]
25. Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies.
Wang Y; Wang XF; Sun ZF; Luo B
Virus Res; 2012 Jun; 166(1-2):23-30. PubMed ID: 22406129
[TBL] [Abstract][Full Text] [Related]
26. Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes.
Tang YL; Lu JH; Cao L; Wu MH; Peng SP; Zhou HD; Huang C; Yang YX; Zhou YH; Chen Q; Li XL; Zhou M; Li GY
Braz J Med Biol Res; 2008 Feb; 41(2):110-6. PubMed ID: 18297191
[TBL] [Abstract][Full Text] [Related]
27. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
Zhang J; Jia L; Tsang CM; Tsao SW
Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China.
Sung NS; Edwards RH; Seillier-Moiseiwitsch F; Perkins AG; Zeng Y; Raab-Traub N
Int J Cancer; 1998 Apr; 76(2):207-15. PubMed ID: 9537582
[TBL] [Abstract][Full Text] [Related]
29. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
Tiwawech D; Srivatanakul P; Karalak A; Ishida T
J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus infection and nasopharyngeal carcinoma.
Tsao SW; Tsang CM; Lo KW
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
32. Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients.
Hadhri-Guiga B; Khabir AM; Mokdad-Gargouri R; Ghorbel AM; Drira M; Daoud J; Frikha M; Jlidi R; Gargouri A
Virus Res; 2006 Jan; 115(1):24-30. PubMed ID: 16154221
[TBL] [Abstract][Full Text] [Related]
33. [The LMP1 oncogene sequence variations in patients with oral tumours associated or not associated with the Epstein Barr].
Gurtsevitch VE; Iakovleva LS; Shcherbak LN; Goncharova EV; Smirnova KV; Diduk SV; Kondratova VN; Maksimovich DM; Lichtenstein AV; Seniuta NB
Mol Biol (Mosk); 2013; 47(6):987-95. PubMed ID: 25509860
[TBL] [Abstract][Full Text] [Related]
34. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma.
Chan JY; Gao W; Ho WK; Wei WI; Wong TS
Anticancer Res; 2012 Aug; 32(8):3201-10. PubMed ID: 22843893
[TBL] [Abstract][Full Text] [Related]
36. Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups.
Wasil LR; Shair KHY
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950426
[TBL] [Abstract][Full Text] [Related]
37. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
38. Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma.
Lin SY; Tsang NM; Kao SC; Hsieh YL; Chen YP; Tsai CS; Kuo TT; Hao SP; Chen IH; Hong JH
Head Neck; 2001 Mar; 23(3):194-200. PubMed ID: 11428449
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
Ji MF; Huang QH; Yu X; Liu Z; Li X; Zhang LF; Wang P; Xie SH; Rao HL; Fang F; Guo X; Liu Q; Hong MH; Ye W; Zeng YX; Cao SM
Cancer; 2014 May; 120(9):1353-60. PubMed ID: 24477877
[TBL] [Abstract][Full Text] [Related]
40. Rearranged Epstein-Barr virus genomes and clonal origin in nasopharyngeal carcinoma.
Shimakage M; Chatani M; Ikegami N; Hirai K
Jpn J Cancer Res; 1989 Jul; 80(7):612-6. PubMed ID: 2551868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
